Skip to content

13F-HR filed by Front Row Advisors LLC

Front Row Advisors LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 512 holding rows worth $260,225,274.

Accession
0001729254-25-000003
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 512 entries on the cover page, a total value of $260,225,274 stated on the cover page (in dollars after the unit check, H1), rows summing to $260,225,274 with VALUE read as dollars as filed, 13F file number 028-18239. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLOCK INC CL A852234103Stock1$54dollars as filed
CONDUENT INC206787103COM20$54dollars as filed
FORD MTR CO COM345370860Stock5$50dollars as filed
ORGANON & CO COMMON STOCK68622V106Stock3$47dollars as filed
Cara Therapeutics Inc OLD140755208COM NEW6$30dollars as filed
LUMEN TECHNOLOGIES INC550241103COM7$27dollars as filed
EKSO BIONICS HLDGS INC282644301COM31$12dollars as filed
AGENUS INC00847G804COM NEW5$8dollars as filed
CARDIFF ONCOLOGY INC14147L108COM2$6dollars as filed
GT BIOPHARMA INC36254L308COM1$2dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK6$2dollars as filed
FIRST REPUBLIC BANK/SAN FRANCI33616C100COM325$1dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001729254-25-000003this filing2025-05-15acceptance time not in the bulk data set